WEARABLE-TECHNOLOGY-SHOW
The Wearable Technology Show returns to London in March for its fourth outing with a strengthened focus on digital health, 6,000 attendees in its sights, global leaders and influencers on its 200-speaker strong conference programme and over 100 exhibitors showcasing the latest innovations in smart technology.
The fourth Wearable Technology Show takes place 7-8 March at ExCeL and is co-located with the AR, VR & MXR Show , IOT Connect and the brand new Digital Health Technology Show , making it Europe’s biggest event for wearables, AR & VR, IOT and connected technology.
Speakers already confirmed for 2017 include the following keynotes:
- Vincent Nida, Global Brand President, L’Oreal
- Greg Ivanov, Business Head, Google Daydream
- Rachel Murphy, Digital Delivery Director, NHS Digital
- Steve Moore, Director of Connected Home, Dixons Carphone
100 exhibitors from more than 20 countries will be on the show floor unveiling brand new products and prototypes, many of which will never have been seen before in Europe. For example:
-
MyndPlay
Fronted by former Apprentice candidate, Tre Azam, MyndPlay is behind the revolutionary VR-ready MyndBand EEG Brainwave headset and the MyndPlayer interactive mind controlled video platform which allows users to control, influence and interact with videogames, apps and movies using their mind and emotions.
-
Navdy
The Navdy Head-Up Display integrates AR with driving, to give you access to distraction-free information on a transparent screen as you drive -
Stretchsense
The leading supplier of smart stretch sensors, Stretchsense’s lightweight, flexible fabric stretch sensors and low-powered circuits can be integrated into garments to feed back precise, real-time motion data to the user’s portable device.
-
Glass Up
GlassUp are the brains behind the UNO smart eyewear, which use AR to give the wearer access to incoming e-mails, texts and social media updates.
And in the Digital Health Technology Show:
-
Touch Surgery
Straight from rave reviews at CES, Touch Surgery is the leading mobile surgical simulation platform with amazing new surgical training capabilities, allowing people to perform next to ‘real-life’ surgical procedures.
-
E-Sense
Also previewed at CES, E-Sense’s Helios Smart Ring has three smart coaches to monitor and coach our Vitamin D, sunlight and daylight intake and exposure
-
Proximie
A revolutionary application transforming the way surgeons work and teach, using an interactive AR platform that gives surgical support seamlessly from anywhere in the world, resulting in better patient care, reduced costs and a highly engaging training experience.
-
Activbody
UK launch of Activ5 wellbeing tool, a wireless-enabled, handheld isometric-based strength training device that, along with the Activ5 Companion App, coaches users through five-minute full body workouts and measures data such as strength, precision and other personal metrics.
“The Wearable Technology Show continues to grow from strength to strength, breaking new boundaries in terms of our global audience, reach and content each year,” commented COO John Weir.
“The launch of the Digital Health Technology Show for 2017 is particularly exciting for visitors: digital health is one of the most innovative, ground-breaking and, literally, life-changing areas of smart technology.”
Registration is open now at http://www.wearabletechnologyshow.net/home
Notes to editors:
About Wearable Technology Show
The Wearable Technology Show is Europe’s biggest event for wearables, AR and VR, IoT and Connected Technology. Over 6,000 are expected to attend this year’s event – the fourth - to hear from some of the top names in wearables, digital health, AR/VR, and IOT. The Wearable Technology Show is co-located with the AR, VR & MXR Show, Europe's largest independent event for AR, VR and Mixed Reality, as well as IOT Connect – dedicated to the connected enterprise.
2017 will also see the launch of the Digital Health Technology Show, where delegates can see the future of healthcare and learn about the latest disruptive technology transforming the medical sector.
With over 200 speakers, the conference programme will deliver the most comprehensive, entertaining and inspiring programme of any technology show around. The Wearable Technology Show boasts ten conference tracks:
- Wearable Disrupt
- Performance Sports
- AR, VR & MXR
- Digital Health Keynote
- Smart Textiles & Sensors
- Smart Home & Connected Living
- IoT Connect
- IoT & Apps Developers
- Innovation Showcase
- Digital Health Innovation
For more information: www.wearabletechnologyshow.net /@wearabletecshow #WTS2017
Press can register for the show at http://www.wearabletechnologyshow.net/press-registration
View source version on businesswire.com: http://www.businesswire.com/news/home/20170123005545/en/
Contact:
BIGTOP PR
Charlie Le Rougetel
07736 330676
charlie@bigtop-pr.co.uk
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Prodalim Expands its Natural Ingredients Portfolio with the Launch of Coloring Foodstuffs and Natural Colors Product Lines, Enhancing Innovation in Upcycled Products16.7.2025 12:18:00 CEST | Press release
Prodalim, a global leader in juice solutions and specialty ingredients, announces the launch of its Coloring Foodstuffs and Natural Colores portfolio, marking a milestone in its commitment to delivering clean-label, plant-based, upcycled product innovations for the food and beverage industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716821011/en/ These natural color solutions are designed for seamless integration into a wide range of applications, including beverages, dairy, plant-based products, bakery, and confectionery. They offer vibrant visual appeal without compromising on performance, health standards, regulatory compliance, or consumer trust. Developed based on strict quality standards, Prodalim’s Coloring portfolio delivers optimal light resistance, pH stability, and thermal performance, addressing real-world formulation challenges while enhancing naturality, clean label credentials, and full “tree-to-table
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom